Key points from article :
Harvard University spinout to put millions behind a rejuvenation discovery.
Elevian to explore daily injections of a protein called GDF11.
May promote the body’s ability to restore itself.
Could treat conditions including coronary artery disease, Alzheimer’s, and sarcopenia.
Elevian said today it has raised $5.5 million in seed funding.
The round was led by Bold Capital.
